Catalent
CTLT
#1573
Rank
โ‚ฌ10.19 B
Marketcap
56,17ย โ‚ฌ
Share price
0.62%
Change (1 day)
71.99%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ4.68 Billion

According to Catalent's latest financial reports the company's total debt is โ‚ฌ4.68 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚ฌ4.47 B10.81%
2022-06-30โ‚ฌ4.03 B47.48%
2021-06-30โ‚ฌ2.73 B1.48%
2020-06-30โ‚ฌ2.69 B3.79%
2019-06-30โ‚ฌ2.59 B11.74%
2018-06-30โ‚ฌ2.32 B27.92%
2017-06-30โ‚ฌ1.81 B8.72%
2016-06-30โ‚ฌ1.67 B-0.24%
2015-06-30โ‚ฌ1.67 B-15.64%
2014-06-30โ‚ฌ1.98 B-3.98%
2013-06-30โ‚ฌ2.06 B-2.41%
2012-06-30โ‚ฌ2.11 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ36.15 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.31 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.87 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ0.21 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA